Ms Elizabeth Jane Johns, ACNP | |
4500 Memorial Dr, Div Medical Oncology, Belleville, IL 62226-5360 | |
(800) 647-2098 | |
(314) 362-3192 |
Full Name | Ms Elizabeth Jane Johns |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 6 Years |
Location | 4500 Memorial Dr, Belleville, Illinois |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164832705 | NPI | - | NPPES |
420066535 | Medicaid | MO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LG0600X | Nurse Practitioner - Gerontology | 209011512 (Illinois) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Memorial Hospital | Belleville, IL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Washington University Physicians In Illinois, Inc | 4789945163 | 98 |
Fairview Heights Medical Group Sc | 6800784083 | 342 |
News Archive
The hair cells of the inner ear have a previously unknown "root" extension that may allow them to communicate with nerve cells and the brain to regulate sensitivity to sound vibrations and head position, researchers at the University of Illinois at Chicago College of Medicine have discovered. Their finding is reported online in advance of print in the Proceedings of the National Academy of Sciences.
Schizophrenia and bipolar disorder have for decades been regarded as two distinct psychotic disorders when it comes to definitions and risk factors.
Military veterans with VA insurance experience low rates of transplantation and high rates of death while on the transplant waiting list, according to a study that will be presented at ASN Kidney Week 2017 October 31–November 5 at the Ernest N. Morial Convention Center in New Orleans, LA.
Ligand Pharmaceuticals Incorporated today announced that data from a Phase I study with its selective androgen receptor modulator (SARM) LGD-4033 was featured today in a poster presentation at the 14th International Congress of Endocrinology in Kyoto, Japan. This Phase I clinical trial was the first study in humans of LGD-4033, and evaluated the safety, tolerability and pharmacokinetic profiles of the molecule in a single escalating dose, double blind, placebo-controlled study in 48 healthy volunteers.
› Verified 5 days ago
Entity Name | Fairview Heights Medical Group Sc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1679503668 PECOS PAC ID: 6800784083 Enrollment ID: O20040309000650 |
News Archive
The hair cells of the inner ear have a previously unknown "root" extension that may allow them to communicate with nerve cells and the brain to regulate sensitivity to sound vibrations and head position, researchers at the University of Illinois at Chicago College of Medicine have discovered. Their finding is reported online in advance of print in the Proceedings of the National Academy of Sciences.
Schizophrenia and bipolar disorder have for decades been regarded as two distinct psychotic disorders when it comes to definitions and risk factors.
Military veterans with VA insurance experience low rates of transplantation and high rates of death while on the transplant waiting list, according to a study that will be presented at ASN Kidney Week 2017 October 31–November 5 at the Ernest N. Morial Convention Center in New Orleans, LA.
Ligand Pharmaceuticals Incorporated today announced that data from a Phase I study with its selective androgen receptor modulator (SARM) LGD-4033 was featured today in a poster presentation at the 14th International Congress of Endocrinology in Kyoto, Japan. This Phase I clinical trial was the first study in humans of LGD-4033, and evaluated the safety, tolerability and pharmacokinetic profiles of the molecule in a single escalating dose, double blind, placebo-controlled study in 48 healthy volunteers.
› Verified 5 days ago
Entity Name | Cep America-illinois Hospitalists, Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1841613403 PECOS PAC ID: 3274765904 Enrollment ID: O20140411001788 |
News Archive
The hair cells of the inner ear have a previously unknown "root" extension that may allow them to communicate with nerve cells and the brain to regulate sensitivity to sound vibrations and head position, researchers at the University of Illinois at Chicago College of Medicine have discovered. Their finding is reported online in advance of print in the Proceedings of the National Academy of Sciences.
Schizophrenia and bipolar disorder have for decades been regarded as two distinct psychotic disorders when it comes to definitions and risk factors.
Military veterans with VA insurance experience low rates of transplantation and high rates of death while on the transplant waiting list, according to a study that will be presented at ASN Kidney Week 2017 October 31–November 5 at the Ernest N. Morial Convention Center in New Orleans, LA.
Ligand Pharmaceuticals Incorporated today announced that data from a Phase I study with its selective androgen receptor modulator (SARM) LGD-4033 was featured today in a poster presentation at the 14th International Congress of Endocrinology in Kyoto, Japan. This Phase I clinical trial was the first study in humans of LGD-4033, and evaluated the safety, tolerability and pharmacokinetic profiles of the molecule in a single escalating dose, double blind, placebo-controlled study in 48 healthy volunteers.
› Verified 5 days ago
Entity Name | Cep America - Illinois Snf Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1073069415 PECOS PAC ID: 8022306737 Enrollment ID: O20161012002933 |
News Archive
The hair cells of the inner ear have a previously unknown "root" extension that may allow them to communicate with nerve cells and the brain to regulate sensitivity to sound vibrations and head position, researchers at the University of Illinois at Chicago College of Medicine have discovered. Their finding is reported online in advance of print in the Proceedings of the National Academy of Sciences.
Schizophrenia and bipolar disorder have for decades been regarded as two distinct psychotic disorders when it comes to definitions and risk factors.
Military veterans with VA insurance experience low rates of transplantation and high rates of death while on the transplant waiting list, according to a study that will be presented at ASN Kidney Week 2017 October 31–November 5 at the Ernest N. Morial Convention Center in New Orleans, LA.
Ligand Pharmaceuticals Incorporated today announced that data from a Phase I study with its selective androgen receptor modulator (SARM) LGD-4033 was featured today in a poster presentation at the 14th International Congress of Endocrinology in Kyoto, Japan. This Phase I clinical trial was the first study in humans of LGD-4033, and evaluated the safety, tolerability and pharmacokinetic profiles of the molecule in a single escalating dose, double blind, placebo-controlled study in 48 healthy volunteers.
› Verified 5 days ago
Entity Name | Washington University Physicians In Illinois, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477076263 PECOS PAC ID: 4789945163 Enrollment ID: O20180227002018 |
News Archive
The hair cells of the inner ear have a previously unknown "root" extension that may allow them to communicate with nerve cells and the brain to regulate sensitivity to sound vibrations and head position, researchers at the University of Illinois at Chicago College of Medicine have discovered. Their finding is reported online in advance of print in the Proceedings of the National Academy of Sciences.
Schizophrenia and bipolar disorder have for decades been regarded as two distinct psychotic disorders when it comes to definitions and risk factors.
Military veterans with VA insurance experience low rates of transplantation and high rates of death while on the transplant waiting list, according to a study that will be presented at ASN Kidney Week 2017 October 31–November 5 at the Ernest N. Morial Convention Center in New Orleans, LA.
Ligand Pharmaceuticals Incorporated today announced that data from a Phase I study with its selective androgen receptor modulator (SARM) LGD-4033 was featured today in a poster presentation at the 14th International Congress of Endocrinology in Kyoto, Japan. This Phase I clinical trial was the first study in humans of LGD-4033, and evaluated the safety, tolerability and pharmacokinetic profiles of the molecule in a single escalating dose, double blind, placebo-controlled study in 48 healthy volunteers.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Ms Elizabeth Jane Johns, ACNP 660 S Euclid Ave, Msc 8056-0910-01, Saint Louis, MO 63110-1010 Ph: (618) 607-1340 | Ms Elizabeth Jane Johns, ACNP 4500 Memorial Dr, Div Medical Oncology, Belleville, IL 62226-5360 Ph: (800) 647-2098 |
News Archive
The hair cells of the inner ear have a previously unknown "root" extension that may allow them to communicate with nerve cells and the brain to regulate sensitivity to sound vibrations and head position, researchers at the University of Illinois at Chicago College of Medicine have discovered. Their finding is reported online in advance of print in the Proceedings of the National Academy of Sciences.
Schizophrenia and bipolar disorder have for decades been regarded as two distinct psychotic disorders when it comes to definitions and risk factors.
Military veterans with VA insurance experience low rates of transplantation and high rates of death while on the transplant waiting list, according to a study that will be presented at ASN Kidney Week 2017 October 31–November 5 at the Ernest N. Morial Convention Center in New Orleans, LA.
Ligand Pharmaceuticals Incorporated today announced that data from a Phase I study with its selective androgen receptor modulator (SARM) LGD-4033 was featured today in a poster presentation at the 14th International Congress of Endocrinology in Kyoto, Japan. This Phase I clinical trial was the first study in humans of LGD-4033, and evaluated the safety, tolerability and pharmacokinetic profiles of the molecule in a single escalating dose, double blind, placebo-controlled study in 48 healthy volunteers.
› Verified 5 days ago
Kelsey Beasley, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3060 Harvest Meadow Dr, Belleville, IL 62221 Phone: 618-792-8887 | |
Ms. Lauren Nicole Marshall, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4500 Memorial Dr, Belleville, IL 62226 Phone: 618-257-5455 Fax: 618-257-4490 | |
Mr. Lito T Rufin, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4500 Memorial Dr, Belleville, IL 62226 Phone: 618-257-6220 | |
Cindy L. Auld, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4600 Memorial Dr, Ste. 400, Belleville, IL 62226 Phone: 618-234-2390 Fax: 618-234-9936 | |
Pamela A O'neal, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 130 Lincoln Place Ct, Belleville, IL 62221 Phone: 618-257-2029 Fax: 618-235-5371 | |
Mrs. Deanna L. Rodenberg, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4550 Memorial Dr, Ste. 340, Belleville, IL 62226 Phone: 618-257-6200 Fax: 618-257-6679 | |
Katherine Ann Combs, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4700 Memorial Dr Ste 250, Belleville, IL 62226 Phone: 618-212-6560 |